UNLABELLED: Inflammatory bowel disease (IBD) shares many immunologic and clinical characteristics with graft versus host disease caused by allogeneic T lymphocytes after hematopoietic cell transplantation. Since maternal cells are known to enter the fetal circulation in a high proportion of pregnancies, we hypothesized that maternal engraftment in the fetus results in immune sequelae that can lead to IBD. METHOD: The presence and extent of maternal microchimerism in tissues and blood samples from patients with Crohn's, Ulcerative colitis (UC), and control groups were determined using kinetic Polymerase Chain Reaction (kPCR) to detect maternal- and patient-specific HLA types. In addition, fluorescent in situ hybridization (FISH) was employed to detect maternal cells in biopsies from patients with IBD. RESULTS: Using kPCR, maternal microchimerism was observed in 9 of the 16 (56%) patients with IBD and 6 out of 15 of the control group (40%) (P=NS). Five of 10 Crohn's patients had evidence of maternal microchimerism (50%) (P=NS). Four of six UC patients had evidence of maternal microchimerism in gut tissues (67%) (P=NS). There was no correlation between maternal michrochimerism and disease activity, disease location or granulomas in patients with IBD. Using FISH, five male Crohn's and five male UC patient's intestinal biopsies were analyzed for maternal microchimerism. No maternal cells were identified. CONCLUSION: There is nothing in the data to suggest that patients with IBD differ from disease controls in their frequency of maternal microchimerism in either blood or gut mucosal tissues. These data suggest that maternal microchimerism in blood and biopsies is a relatively common phenomenon that has neither positive nor negative impact on IBD.
UNLABELLED: Inflammatory bowel disease (IBD) shares many immunologic and clinical characteristics with graft versus host disease caused by allogeneic T lymphocytes after hematopoietic cell transplantation. Since maternal cells are known to enter the fetal circulation in a high proportion of pregnancies, we hypothesized that maternal engraftment in the fetus results in immune sequelae that can lead to IBD. METHOD: The presence and extent of maternal microchimerism in tissues and blood samples from patients with Crohn's, Ulcerative colitis (UC), and control groups were determined using kinetic Polymerase Chain Reaction (kPCR) to detect maternal- and patient-specific HLA types. In addition, fluorescent in situ hybridization (FISH) was employed to detect maternal cells in biopsies from patients with IBD. RESULTS: Using kPCR, maternal microchimerism was observed in 9 of the 16 (56%) patients with IBD and 6 out of 15 of the control group (40%) (P=NS). Five of 10 Crohn's patients had evidence of maternal microchimerism (50%) (P=NS). Four of six UC patients had evidence of maternal microchimerism in gut tissues (67%) (P=NS). There was no correlation between maternal michrochimerism and disease activity, disease location or granulomas in patients with IBD. Using FISH, five male Crohn's and five male UC patient's intestinal biopsies were analyzed for maternal microchimerism. No maternal cells were identified. CONCLUSION: There is nothing in the data to suggest that patients with IBD differ from disease controls in their frequency of maternal microchimerism in either blood or gut mucosal tissues. These data suggest that maternal microchimerism in blood and biopsies is a relatively common phenomenon that has neither positive nor negative impact on IBD.
Authors: J G Ocejo-Vinyals; M J Lozano; P Sánchez-Velasco; J Escribano de Diego; J E Paz-Miguel; F Leyva-Cobián Journal: Arch Dis Child Date: 2000-08 Impact factor: 3.791
Authors: David L Suskind; Philip Rosenthal; Melvin B Heyman; Denice Kong; Greg Magrane; Lee-Ann Baxter-Lowe; Marcus O Muench Journal: BMC Gastroenterol Date: 2004-07-31 Impact factor: 3.067
Authors: Emma E Thompson; Rachel A Myers; Gaixin Du; Tessa M Aydelotte; Christopher J Tisler; Debra A Stern; Michael D Evans; Penelope E Graves; Daniel J Jackson; Fernando D Martinez; James E Gern; Anne L Wright; Robert F Lemanske; Carole Ober Journal: J Allergy Clin Immunol Date: 2013-02-21 Impact factor: 10.793
Authors: Janine van der Giessen; Vivian W Huang; C Janneke van der Woude; Gwenny M Fuhler Journal: Clin Transl Gastroenterol Date: 2019-03 Impact factor: 4.488
Authors: Carol M Artlett; Sihem Sassi-Gaha; Ronald C Ramos; Frederick W Miller; Lisa G Rider Journal: Arthritis Res Ther Date: 2015-09-04 Impact factor: 5.156
Authors: Anna Maria Jonsson Kanold; Elisabet Svenungsson; Iva Gunnarsson; Cecilia Götherström; Leonid Padyukov; Nikos Papadogiannakis; Mehmet Uzunel; Magnus Westgren Journal: PLoS One Date: 2013-09-11 Impact factor: 3.240